The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
Open accessAbstract
Superparamagnetic iron oxide nanoparticles have diverse diagnostic and potential therapeutic applications in the central nervous system (CNS). They are useful as magnetic resonance imaging (MRI) contrast agents to evaluate: areas of blood-brain barrier (BBB) dysfunction related to tumors and other neuroinflammatory pathologies, the cerebrovasculature using perfusion-weighted MRI sequences, and in vivo cellular tracking in CNS disease or injury. Novel, targeted, nanoparticle synthesis strategies will allow for a rapidly expanding range of applications in patients with brain tumors, cerebral ischemia or stroke, carotid atherosclerosis, multiple sclerosis, traumatic brain injury, and epilepsy. These strategies may ultimately improve disease detection, therapeutic monitoring, and treatment efficacy especially in the context of antiangiogenic chemotherapy and antiinflammatory medications. The purpose of this review is to outline the current status of superparamagnetic iron oxide nanoparticles in the context of biomedical nanotechnology as they apply to diagnostic MRI and potential therapeutic applications in neurooncology and other CNS inflammatory conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many iron oxide nanoparticles have been evaluated in preclinical and clinical trials, and several of them have reached the market (Table 1) [4, 22–26].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,681
Recent advances in iron oxide nanocrystal technology for medical imaging☆
Corot, C., Robert, P., Idée, J., & Port, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.013 · Cited by 1,461
Perfusion imaging with NMR contrast agents
Rosen, B. R., Belliveau, J. W., Vevea, J. M., & Brady, T. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140211 · Cited by 1,141
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L. J. A., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,120
Weissleder, R., Elizondo, G., WITTENBERG, J., Rabito, C. A., Bengele, H. H., & Josephson, L. (1990) · Radiology · doi:10.1148/radiology.175.2.2326474 · Cited by 1,027
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., & Hochberg, F. H. (1994) · Radiology · doi:10.1148/radiology.191.1.8134596 · Cited by 905
Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C.-M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.050 · Cited by 901
Research works printed but not linked: 15
- Barnett PA, 1995, Am J Pathol, 146, 436
- Cameron DG, 1951, Can Med Assoc J, 64, 27
- Chang KH, 1994, AJNR Am J Neuroradiol, 15, 1413
- Dousset V, 2006, AJNR Am J Neuroradiol, 27, 1000
- Hunt MA, 2005, AJNR Am J Neuroradiol, 26, 1084
- Kraemer DF, 2001, Neurosurgery, 48, 1033
- Kremer S, 2002, J Neuroradiol, 29, 105
- Lev MH, 2004, AJNR Am J Neuroradiol, 25, 214
- Manninger SP, 2005, AJNR Am J Neuroradiol, 26, 2290
- Miki Y, 1997, AJNR Am J Neuroradiol, 18, 705
- Moseley ME, 1990, AJNR Am J Neuroradiol, 11, 423
- Muldoon LL, 2006, AJNR Am J Neuroradiol, 27, 715
- Soroceanu L, 1998, Cancer Res, 58, 4871
- Varallyay P, 2002, AJNR Am J Neuroradiol, 23, 510
- Yuh WT, 1991, AJNR Am J Neuroradiol, 12, 621
Cited by
Sorted by citations
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, M., & Arora, S. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,148
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Sadhasivam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,103
Engaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C. M., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O’Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2995 · Cited by 594
Self-citationExceedingly small iron oxide nanoparticles as positive MRI contrast agents
Wei, H., Bruns†, O. T., Kaul, M. G., Hansen, E. C., Barch, M., Wiśniowska, A. E., Chen, O., Chen, Y., Li, N., Okada, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620145114 · Cited by 500
Hadjipanayis, C. G., Machaidze, R., Kaluzová, M., Wang, L., Schuette, A. J., Chen, H., Wu, X., & Mao, H. Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1022 · Cited by 428
Ünsoy, G., Yalçın, S., Khodadust, R., Gündüz, G., & Gündüz, U. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0964-8 · Cited by 353
Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
Muldoon, L. L., Alvarez, J. I., Begley, D. J., Boado, R. J., del Zoppo, G. J., Doolittle, N. D., Engelhardt, B., Hallenbeck, J. M., Lonser, R. R., Ohlfest, J. R., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.153 · Cited by 342
Self-citationYarjanli, Z., Ghaedi, K., Esmaeili, A., Rahgozar, S., & Zarrabi, A. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0369-9 · Cited by 303
Iron oxide nanorods as high-performance magnetic resonance imaging contrast agents
Mohapatra, J., Mitra, A., Tyagi, H., Bahadur, D., & Aslam, M. (2015) · Nanoscale · doi:10.1039/c5nr00055f · Cited by 276
Engineered nanoparticles for biomolecular imaging
Mahmoudi, M., Serpooshan, V., & Laurent, S. (2011) · Nanoscale · doi:10.1039/c1nr10326a · Cited by 262
Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
Huang, Y., Hsu, J. C., Koo, H., & Cormode, D. P. (2021) · Theranostics · doi:10.7150/thno.67375 · Cited by 265
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
Ciccarelli, O., Barkhof, F., Bodini, B., Stefano, N. D., Golay, X., Nicolay, K., Pelletier, D., Pouwels, P. J. W., Smith, S. A., Wheeler‐Kingshott, C. A. M. G., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70101-2 · Cited by 253
Magnetic Nanoparticles in Magnetic Resonance Imaging and Diagnostics
Rümenapp, C., Gleich, B., & Haase, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0711-y · Cited by 246
Cai, N., Li, C. L., Han, C., Luo, X., Shen, L., Xue, Y., & Yu, F. (2016) · Applied Surface Science · doi:10.1016/j.apsusc.2016.02.053 · Cited by 231
Magnetic iron oxide nanoparticles as T 1 contrast agents for magnetic resonance imaging
Bao, Y., Sherwood, J. A., & Sun, Z. (2018) · Journal of Materials Chemistry C · doi:10.1039/c7tc05854c · Cited by 224
de Sousa, M. E., van Raap, M. B. F., Rivas, P. C., Zélis, P. M., Girardin, P., Pasquevich, G. A., Alessandrini, J. L., Muraca, D., & Sánchez, F. H. (2013) · The Journal of Physical Chemistry C · doi:10.1021/jp311556b · Cited by 199
Gamma-irradiation applied in the synthesis of metallic and organic nanoparticles: A short review
Flores‐Rojas, G. G., López‐Saucedo, F., & Bucio, E. (2018) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2018.08.011 · Cited by 186
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes
Laman, J. D., & Weller, R. O. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9470-8 · Cited by 168
Iron oxide nanoparticles in modern microbiology and biotechnology
Ranmadugala, D., Ebrahiminezhad, A., Manley‐Harris, M., Ghasemi, Y., & Berenjian, A. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1267708 · Cited by 167
Gahramanov, S., Muldoon, L. L., Varallyay, C. G., Li, X., Kraemer, D. F., Fu, R., Hamilton, B. E., Rooney, W. D., & Neuwelt, E. A. (2013) · Radiology · doi:10.1148/radiol.12111472 · Cited by 162
Self-citationSchuemann, J., Bagley, A. F., Berbeco, R. I., Bromma, K., Butterworth, K. T., Byrne, H. L., Chithrani, D. B., Cho, S. H., Cook, J. R., Favaudon, V., et al. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab9159 · Cited by 165
Hu, B., Dai, F., Fan, Z., Ma, G., Tang, Q., & Zhang, X. (2015) · Advanced Materials · doi:10.1002/adma.201502227 · Cited by 155
Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics
Ding, H. Y., & Wu, F. P. (2012) · Theranostics · doi:10.7150/thno.4652 · Cited by 159
Gahramanov, S., Raslan, A. M., Muldoon, L. L., Hamilton, B. E., Rooney, W. D., Várallyay, C. G., Njus, J. M., Haluska, M., & Neuwelt, E. A. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.072 · Cited by 151
Self-citationHasan, D. M., Chalouhi, N., Jabbour, P. M., Dumont, A. S., Kung, D. K., Magnotta, V. A., Young, W. L., Hashimoto, T. N., Winn, H. R., & Heistad, D. D. (2012) · Stroke · doi:10.1161/strokeaha.112.673400 · Cited by 151
Singh, N., Jenkins, G. J. S., Nelson, B. C., Marquis, B. J., Maffeïs, T. G. G., Brown, A., Williams, P. M., Wright, C. J., & Doak, S. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.087 · Cited by 150
Lévy, M., Quarta, A., Espinosa, A., Figuerola, A., Wilhelm, C., Garcı́a-Hernández, M., Genovese, A., Falqui, A., Alloyeau, D., Buonsanti, R., et al. (2011) · Chemistry of Materials · doi:10.1021/cm201078f · Cited by 155
Yılmaz, A., Dengler, M. A., van der Kuip, H., Yildiz, H., Rösch, S., Klumpp, S., Klingel, K., Kandolf, R., Helluy, X., Hiller, K., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs366 · Cited by 149
On-demand drug delivery from local depots
Brudno, Y., & Mooney, D. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.011 · Cited by 148
Assessing Iron Oxide Nanoparticle Toxicity In Vitro : Current Status and Future Prospects
Soenen, S. J., & Cuyper, M. D. (2010) · Nanomedicine · doi:10.2217/nnm.10.106 · Cited by 152
Park, E., Kim, H., Kim, Y., Yi, J., Choi, K., & Park, K. (2010) · Toxicology · doi:10.1016/j.tox.2010.06.002 · Cited by 144
Ittrich, H., Peldschus, K., Raabe, N., Kaul, M. G., & Adam, G. (2013) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0033-1335438 · Cited by 149
Contrast agents in diagnostic imaging: Present and future
Caschera, L., Lazzara, A., Piergallini, L., Ricci, D., Tuscano, B., & Vanzulli, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.023 · Cited by 139
SPION primes THP1 derived M2 macrophages towards M1-like macrophages
Laskar, A., Eilertsen, J., Li, W., & Yuan, X.-M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.115 · Cited by 138
Vascular Imaging With Ferumoxytol as a Contrast Agent
Hope, M. D., Hope, T. A., Zhu, C., Faraji, F., Haraldsson, H., Ordovas, K. G., & Saloner, D. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.15.14534 · Cited by 137
Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies
Béchet, D., Mordon, S. R., Guillemin, F. H., & Barberi‐Heyob, M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.004 · Cited by 145
Davis, H. C., Ramesh, P., Bhatnagar, A., Lee‐Gosselin, A., Barry, J. F., Glenn, D. R., Walsworth, R. L., & Shapiro, M. G. (2018) · Nature Communications · doi:10.1038/s41467-017-02471-7 · Cited by 137
Yang, J., Zaim Wadghiri, Y., Minh Hoang, D., Tsui, W., Sun, Y., Chung, E., Li, Y., Wang, A., de Leon, M., & Wisniewski, T. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.023 · Cited by 135
Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors
Iv, M., Telischak, N., Feng, D., Holdsworth, S. J., Yeom, K. W., & Daldrup-Link, H. E. (2015) · Nanomedicine · doi:10.2217/nnm.14.203 · Cited by 134
Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications
Loomis, K. H., McNeeley, K. M., & Bellamkonda, R. V. (2010) · Soft Matter · doi:10.1039/c0sm00534g · Cited by 133
Dual and multi-targeted nanoparticles for site-specific brain drug delivery
Luo, Y., Yang, H., Zhou, Y., & Hu, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.037 · Cited by 132
Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy
Martinková, P., Brtnický, M., Kynický, J., & Pohanka, M. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700932 · Cited by 126
Therapeutic Nanomedicine for Brain Cancer
Tzeng, S. Y., & Green, J. J. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.38 · Cited by 124
Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles
Boros, E., Bowen, A. M., Josephson, L., Vasdev, N., & Holland, J. P. (2014) · Chemical Science · doi:10.1039/c4sc02778g · Cited by 121
Nanoparticles: Novel vehicles in treatment of Glioblastoma
Pourgholi, F., Hajivalili, M., Jadidi‐Niaragh, F., Kafil, H. S., & Yousefi, M. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.014 · Cited by 120
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases
Gendelman, H. E., Anantharam, V., Bronich, T. K., Ghaisas, S., Jin, H., Kanthasamy, A. G., Liu, X., McMillan, J., Mosley, R. L., Narasimhan, B., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.014 · Cited by 118
Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era
Huang, T., Li, X., Maier, M., O’brien-simpson, N. M., Heath, D. E., & O’Connor, A. J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.01.019 · Cited by 117
Applications of Nanoparticles in Nanomedicine
Yohan, D., & Chithrani, D. B. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.2015 · Cited by 120
Kim, M. M., Umemura, Y., & Leung, D. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000326 · Cited by 118
Hasan, D. M., Mahaney, K. B., Magnotta, V. A., Kung, D. K., Lawton, M. T., Hashimoto, T. N., Winn, H. R., Saloner, D., Martin, A. J., Gahramanov, S., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.239871 · Cited by 113
Self-citationThe paradoxical effect of bevacizumab in the therapy of malignant gliomas
Thompson, E. M., Frenkel, E. P., & Neuwelt, E. A. (2010) · Neurology · doi:10.1212/wnl.0b013e318204a3af · Cited by 112
Self-citationCommercial Nanoparticles for Stem Cell Labeling and Tracking
Wang, Y., Xu, C., & Ow, H. (2013) · Theranostics · doi:10.7150/thno.5634 · Cited by 113
Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes
Gaharwar, U. S., Meena, R., & Rajamani, P. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3485 · Cited by 112
Nanopharmaceuticals (part 2): products in the pipeline
Weissig, V., & Guzman‐Villanueva, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s65526 · Cited by 110
Targeting specific cells in the brain with nanomedicines for CNS therapies
Zhang, F., Lin, Y.-A., Kannan, S., & Kannan, R. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.013 · Cited by 113
Srinivas, A., Rao, P. J., Selvam, G. S., Anumolu, G., Murthy, B., & Reddy, N. P. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112446515 · Cited by 106
Várallyay, C. G., Nesbit, E. G., Fu, R. F., Gahramanov, S., Moloney, B., Earl, E., Muldoon, L. L., Li, X., Rooney, W. D., & Neuwelt, E. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.36 · Cited by 104
Self-citationSuperparamagnetic iron oxide based nanoprobes for imaging and theranostics
Lam, T., Pouliot, P., Avti, P., Lesage, F., & Kakkar, A. K. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.06.007 · Cited by 105
Prilepskii, A. Y., Fakhardo, A. F., Drozdov, A. S., Vinogradov, V. V., Dudanov, I. P., Shtil, A. A., Beltyukov, P. P., Shibeko, A. M., Михайловна, К. Е., Nechipurenko, D. Y., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14790 · Cited by 105
Nasseri, M. N., Gahramanov, S., Netto, J. P., Fu, R., Muldoon, L. L., Várallyay, C. G., Hamilton, B. E., & Neuwelt, E. A. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not328 · Cited by 101
Self-citationStem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview
Accomasso, L., Gallina, C., Turinetto, V., & Giachino, C. (2015) · Stem Cells International · doi:10.1155/2016/7920358 · Cited by 103
An update on nanoparticle-based contrast agents in medical imaging
Naseri, N., Ajorlou, E., Asghari, F., & Pilehvar‐Soltanahmadi, Y. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1379014 · Cited by 100
Multifunctional polyglycerol-grafted Fe3O4@SiO2 nanoparticles for targeting ovarian cancer cells
Wang, L., Neoh, K. G., Kang, E. T., & Shuter, B. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.042 · Cited by 100
Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease
Lameijer, M., Tang, J., Nahrendorf, M., Beelen, R. H. J., & Mulder, W. J. M. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.819216 · Cited by 98
Wei, K., Xu, X., Pu, X., Zhenqing, H., & Qiqing, Z. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-480 · Cited by 101
Delivery of Chemotherapeutics Across the Blood–Brain Barrier
Doolittle, N. D., Muldoon, L. L., Culp, A. Y., & Neuwelt, E. A. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.002 · Cited by 97
Self-citationSaraswathy, A., Nazeer, S. S., Nimi, N., Sabareeswaran, A., Shenoy, S. J., & Jayasree, R. S. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.10.015 · Cited by 96
Gutova, M., Frank, J. A., D’Apuzzo, M., Khankaldyyan, V., Gilchrist, M., Annala, A. J., Metz, M. Z., Abramyants, Y., Herrmann, K. A., Ghoda, L. Y., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0049 · Cited by 94
Srivastava, S., Awasthi, R., Gajbhiye, N. S., Agarwal, V., Singh, A., Yadav, A., & Gupta, R. K. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.03.059 · Cited by 93
Iron Oxide Nanoparticles in Bioimaging – An Immune Perspective
Geppert, M., & Himly, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688927 · Cited by 95
Ma, B., Xu, H., Zhuang, W., Wang, Y., Li, G., & Wang, Y. (2020) · Small · doi:10.1002/smll.202003253 · Cited by 91
Uptake and Metabolism of Iron Oxide Nanoparticles in Brain Cells
Petters, C., Irrsack, E., Koch, M., & Dringen, R. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1380-5 · Cited by 88
Han, C., Cai, N., Chan, V., Liu, M., Feng, X., & Yu, F. (2018) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2018.09.012 · Cited by 87
Wu, H., Chung, M., Wang, C., Huang, C., Liang, H., & Jan, T. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-46 · Cited by 83
Escamilla‐Rivera, V., Uribe-Ramírez, M., González‐Pozos, S., Lozano, O., Lucas, S., & Vizcaya‐Ruíz, A. D. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.10.018 · Cited by 82
Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes
Geppert, M., Hohnholt, M. C., Thiel, K., Nürnberger, S., Grunwald, I., Rezwan, K., & Dringen, R. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/14/145101 · Cited by 80
Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles
Sharma, A., Cornejo, C. M., Mihalic, J. N., Geyh, A. S., Bordelon, D. E., Korangath, P. C., Westphal, F., Gruettner, C., & Ivkov, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-23317-2 · Cited by 79
Geppert, M., Hohnholt, M. C., Nürnberger, S., & Dringen, R. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.06.029 · Cited by 77
Engineered Inorganic Nanoparticles for Drug Delivery Applications
Ojea‐Jiménez, I., Comenge, J., García-Fernández, L., Megson, Z., Casals, E., & Puntes, V. (2013) · Current Drug Metabolism · doi:10.2174/13892002113149990008 · Cited by 76
Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.
Nunes, A., Al-Jamal, K. T., & Kostarelos, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.026 · Cited by 75
Laskar, A., Ghosh, M., Khattak, S. I., Li, W., & Yuan, X. (2012) · Nanomedicine · doi:10.2217/nnm.11.148 · Cited by 75
Nanotechnology for the Detection and Therapy of Stroke
Kyle, S., & Saha, S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400009 · Cited by 76
Hohnholt, M. C., Geppert, M., & Dringen, R. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.06.052 · Cited by 73
Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells
Luther, E. M., Petters, C., Bulcke, F., Kaltz, A., Thiel, K., Bickmeyer, U., & Dringen, R. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.05.022 · Cited by 73
MRI Using Ferumoxytol Improves the Visualization of Central Nervous System Vascular Malformations
Dósa, E., Tuladhar, S., Muldoon, L. L., Hamilton, B. E., Rooney, W. D., & Neuwelt, E. A. (2011) · Stroke · doi:10.1161/strokeaha.110.607994 · Cited by 72
Self-citationFerumoxytol in clinical practice: Implications for MRI
McCullough, B. J., Kolokythas, O., Maki, J. H., & Green, D. E. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23879 · Cited by 72
Gadolinium-coordinated elastic nanogels for in vivo tumor targeting and imaging
Lim, C., Singh, A. K., Heo, J., Kim, D., Lee, K. E., Jeon, H., Koh, J., Kwon, I. C., & Kim, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.069 · Cited by 72
George, C., Dorfs, D., Bertoni, G., Falqui, A., Genovese, A., Pellegrino, T., Roig, A., Quarta, A., Comparelli, R., Curri, M. L., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108781w · Cited by 72
Applications of magnetic nanoparticles in biomedical separation and purification
Yıldız, İ. (2015) · Nanotechnology Reviews · doi:10.1515/ntrev-2015-0012 · Cited by 72
Li, L., Nurunnabi, M., Nafiujjaman, M., Jeong, Y. Y., Lee, Y.-K., & Huh, K. M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00181h · Cited by 70
Millward, J. M., Schnorr, J., Taupitz, M., Wagner, S., Wuerfel, J. T., & Infante‐Duarte, C. (2013) · ASN NEURO · doi:10.1042/an20120081 · Cited by 72
Improved magnetic regulation of delivery profiles from ferrogels
Kennedy, S. M., Roco, C. M., Déléris, A., Spoerri, P., Cezar, C. A., Weaver, J. C., Vandenburgh, H. H., & Mooney, D. J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.049 · Cited by 69
Preclinical hazard evaluation strategy for nanomedicines
Siegrist, S., Çörek, E., Detampel, P., Sandström, J., Wick, P., & Huwyler, J. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1505000 · Cited by 69
Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL
Farrell, B. T., Hamilton, B. E., Dósa, E., Rimely, E., Nasseri, M. N., Gahramanov, S., Lacy, C. A., Frenkel, E. P., Doolittle, N. D., Jacobs, P. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829bfd8f · Cited by 67
Self-citationRodrigues, R. O., Bañobre‐López, M., Gallo, J., Tavares, P. B., Silva, A. M. T., Lima, R. A., & Gomes, H. T. (2016) · Journal of Nanoparticle Research · doi:10.1007/s11051-016-3498-7 · Cited by 66
A Review on the Recent Advancements on Therapeutic Effects of Ions in the Physiological Environments
Awais, M., Aizaz, A., Nazneen, A., Bhatti, Q. U. A., Akhtar, M., Wadood, A., & Rehman, M. A. U. (2022) · Prosthesis · doi:10.3390/prosthesis4020026 · Cited by 66
The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival
Thompson, E. M., Keir, S. T., Venkatraman, T. N., Lascola, C. D., Yeom, K. W., Nixon, A. B., Liu, Y., Picard, D. J., Remke, M., Bigner, D. D., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox033 · Cited by 65
Human-scale navigation of magnetic microrobots in hepatic arteries
Li, N., Fei, P., Tous, C., Adariani, M. R., Hautot, M.-L., Ouedraogo, I., Hadjadj, A., Dimov, I. P., Zhang, Q., Lessard, S., et al. (2024) · Science Robotics · doi:10.1126/scirobotics.adh8702 · Cited by 69
Liu, R., Liu, J., Tong, J. Q., Tang, T., Kong, W., Wang, X., Li, Y., & Tang, J. (2012) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2011.12.006 · Cited by 64
Metadata
- Authors
- Weinstein, J. S., Varallyay, C. G., Dosa, E., Gahramanov, S., Hamilton, B., Rooney, W. D., Muldoon, L. L., & Neuwelt, E. A.
- Affiliations
- Oregon Health & Science University (US)
- Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA
- Corresponding author
- Neuwelt, Edward A
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2009-09-16
- Volume
- 30
- Issue
- 1
- Pages
- 15-35
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC2949106
- OpenAlex
- W2059756358
- Cited by
- 500
- References
- 126
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 21 · 2023: 24 · 2022: 21 · 2021: 20 · 2020: 18 · 2019: 32 · 2018: 41 · 2017: 37 · 2016: 33 · 2015: 41 · 2014: 41 · 2013: 51 · 2012: 41
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 33618, R01NS053468, NS053468, R37NS044687, NS34608, R01NS033618, R01NS044687, R01NS034608, NS-44687)
- National Institute of Biomedical Imaging and Bioengineering (R01EB007258)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- superparamagnetic iron oxide nanoparticles, MRI contrast agents, neuro-oncology, brain tumors, blood-brain barrier dysfunction, neuroinflammation, perfusion-weighted MRI, cerebrovascular imaging, cell tracking, cerebral ischemia, stroke, carotid atherosclerosis, multiple sclerosis, traumatic brain injury, epilepsy, anti-inflammatory therapy, nanomedicine
- MeSH terms
- Animals, Blood-Brain Barrier, Contrast Media, Electron Spin Resonance Spectroscopy, Ferric Compounds, Humans, Inflammation, Magnetic Resonance Imaging, Particle Size, Central Nervous System Neoplasms, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review